From: Neutralization sensitivity of HIV-1 subtype B’ clinical isolates from former plasma donors in China
Virus (co-receptor usage) | Neutralizing activity (ID50 titer, 1/x) of plasma from HIV-1 CRF07_BC infected patients | ||||||||
---|---|---|---|---|---|---|---|---|---|
XJ256P | XJ257P | XJ0135P | XJ6291P | XJ6371P | XJ0793P | XJ1353P | XJ1981P | Mean | |
AH096V (R5) | ― | ― | 10 | 10 | 28 | ― | ― | ― | 11.0 |
AH104V (X4R5) | ― | ― | ― | ― | 13 | ― | ― | ― | 8.6 |
AH259V ( R5) | ― | ― | ― | ― | ― | ― | ― | ― | ― |
AH311V (X4R5) | ― | ― | 10 | ― | 27 | ― | ― | ― | 10.6 |
AH374V (X4R5) | ― | ― | ― | 368 | ― | ― | ― | ― | 53.0 |
AH968V (R5) | ― | ― | ― | ― | 35 | ― | ― | ― | 11.4 |
AH419V (R5) | ― | ― | ― | ― | ― | ― | ― | ― | ― |
AH628V (R5) | ― | ― | ― | ― | ― | ― | 13 | ― | 8.6 |
AH634V (R5) | 20 | ― | ― | 11 | 18 | ― | 24 | ― | 13.1 |
AH691V (R5) | 16 | ― | ― | ― | ― | ≥ 648 | 41 | 22 | 94.9 |
AH1188V (X4R5) | 16 | 20 | ― | ― | 20 | 10 | 29 | 24 | 16.9 |
AH1597V (R5) | 18 | ― | 54 | 10 | 21 | ― | 17 | ― | 18.0 |
Mean | 11.2 | 9.0 | 12.2 | 38.6 | 16.8 | 61.5 | 15.0 | 10.5 | |
SF33(X4R5)* | 160 | ≥ 648 | ― | ― | 236 | 304 | 56 | 316 |